Lijun Xu

机构：Nanchang University, Guiyang Medical University, Palo Alto University, Second Affiliated Hospital of Nanchang University, Affiliated Hospital of Guizhou Medical University, Stanford Medicine · ORCID：0000-0003-0455-410X

发表论文 66 篇 · 总被引 2128 次 · h-index 20

代表论文

• Prevalence of sufficient physical activity among general adult population and sub-populations with chronic conditions or disability in the USA (2023 · European Journal of Public Health · 被引 27)
• A human TRPV1 genetic variant within the channel gating domain regulates pain sensitivity in rodents (2022 · Journal of Clinical Investigation · 被引 23)
• Large-scale analysis of 2,152 Ig-seq datasets reveals key features of B cell biology and the antibody repertoire (2021 · Cell Reports · 被引 23)
• Romidepsin and metformin nanomaterials delivery on streptozocin for the treatment of Alzheimer's disease in animal model (2021 · Biomedicine & Pharmacotherapy · 被引 21)
• Caspase-1/IL-1β represses membrane transport of GluA1 by inhibiting the interaction between Stargazin and GluA1 in Alzheimer’s disease (2021 · Molecular Medicine · 被引 19)
• Hydroxysafflor yellow A can improve depressive behavior by inhibiting hippocampal inflammation and oxidative stress through regulating HPA axis (2022 · Journal of Biosciences · 被引 13)